Severe COVID-19 Detected Earlier by Biomarker
To identify and treat COVID-19 patients at an early stage, predictive biomarkers need to be identified; researchers have discovered one.
Read More
Search Results for: lung cancer
Biodesix Announces Liquid Biopsy NGS Test with 72-Hour Turnaround
The study showed that the rapid liquid biopsy NGS test was able to accurately detect actionable genomic alterations in patients with NSCLC with a turnaround time of only 72 hours.
Read More
Guardant Health Raising Awareness of Importance of Complete Biomarker Testing for Advanced Colorectal Cancer
Guardant Health is joining forces with leading patient advocacy groups to expand the Clear Your View initiative to raise awareness of the important role complete biomarker testing plays in guiding initial treatment decisions for newly diagnosed advanced colorectal cancer patients.
Read More
Agilent to Acquire Resolution Bioscience
The acquisition of Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics.
Read More
Advances in Liquid Biopsy
Developing technology ushers in a new era in precision oncology.
Read More